Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4080024
Max Phase: Preclinical
Molecular Formula: C40H51BrN10O6
Molecular Weight: 847.82
Molecule Type: Small molecule
Associated Items:
ID: ALA4080024
Max Phase: Preclinical
Molecular Formula: C40H51BrN10O6
Molecular Weight: 847.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)NN(Cc1ccc(Br)cc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
Standard InChI: InChI=1S/C40H51BrN10O6/c1-24(43)36(53)48-34(21-28-22-45-31-13-7-6-12-30(28)31)38(55)46-25(2)37(54)50-51(23-27-15-17-29(41)18-16-27)40(57)49-33(20-26-10-4-3-5-11-26)39(56)47-32(35(44)52)14-8-9-19-42/h3-7,10-13,15-18,22,24-25,32-34,45H,8-9,14,19-21,23,42-43H2,1-2H3,(H2,44,52)(H,46,55)(H,47,56)(H,48,53)(H,49,57)(H,50,54)/t24-,25-,32-,33+,34+/m0/s1
Standard InChI Key: IJMRWHOFMZHSMB-KSUJVURRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 847.82 | Molecular Weight (Monoisotopic): 846.3176 | AlogP: 1.76 | #Rotatable Bonds: 19 |
Polar Surface Area: 259.66 | Molecular Species: BASE | HBA: 8 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.22 | CX Basic pKa: 17.02 | CX LogP: 1.01 | CX LogD: -1.80 |
Aromatic Rings: 4 | Heavy Atoms: 57 | QED Weighted: 0.05 | Np Likeness Score: -0.21 |
1. Chignen Possi K, Mulumba M, Omri S, Garcia-Ramos Y, Tahiri H, Chemtob S, Ong H, Lubell WD.. (2017) Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators., 60 (22): [PMID:29028172] [10.1021/acs.jmedchem.7b01209] |
Source(1):